IVY TODD: Open Payments
NPI 1871914366 · CARY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$551 in 30 payments from 8 companies in 2025. Trend: 2023 $358 · 2024 $630 · 2025 $551
Food & beverage: $551
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $284 |
| Lilly USA, LLC | 5 | $95 |
| ABBVIE INC. | 4 | $79 |
| PFIZER INC. | 1 | $21 |
| Exact Sciences Corporation | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Cranial Technologies, Inc | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: Wegovy, Rybelsus, MOUNJARO, Ozempic, UBRELVY, ZEPBOUND, QULIPTA, NURTEC ODT.
Industry payments across NC — which companies pay providers there.
